Companies · Listed company · 🇮🇳

CARE Ratings Limited

CARERATING · NSE · ₹1,603 a share (close of 01 Oct 2026)

Available company data, source links and archived checks for CARE Ratings Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Revenue rose 18.9%; Net profit was ₹32.99 crore.

Quarter ended 2026-06-30 · consolidated · Company filing

Recorded quarterly figures

Quarter	Revenue / income	YoY	Profit	YoY	Net margin	Source
Jun 2026	Revenue: ₹112 cr	+18.9%	Net profit: ₹33 cr	+24.5%	29.5%	Company filing source
Mar 2026	Revenue: ₹131 cr	+19.2%	Net profit: ₹53 cr	+23.2%	40.9%	Company filing source
Dec 2025	Revenue: ₹112 cr	—	Net profit: ₹37 cr	—	32.6%	Company filing source
Sep 2025	Revenue: ₹136 cr	—	Net profit: ₹57 cr	—	42.0%	Company filing source
Jun 2025	Revenue: ₹94 cr	+19.0%	Net profit: ₹26 cr	+23.9%	28.2%	Company filing source
Mar 2025	Revenue: ₹110 cr	—	Net profit: ₹43 cr	—	39.6%	Company filing source

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

Recently checked facts

CARERATING: consolidated net profit changed by 24.5% in the quarter ending 30 June 2026, compared with the quarter ending 2025-06-30.

✓ verified by recomputing archived check · 2026-09-16 exchange filing →

CARERATING: consolidated net profit for the quarter ending 30 June 2026 was ₹32.99 crore.

✓ verified by recomputing archived check · 2026-09-16 exchange filing →

CARERATING: consolidated revenue changed by 18.9% in the quarter ending 30 June 2026, compared with the quarter ending 2025-06-30.

✓ verified by recomputing archived check · 2026-09-16 exchange filing →

CARERATING: consolidated revenue for the quarter ending 30 June 2026 was ₹111.68 crore.

✓ verified by recomputing archived check · 2026-09-16 exchange filing →

Who holds it — from the filings

CRISIL LIMITED 8.7%LIFE INSURANCE CORPORATION OF INDIA 8.5%NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MUL 7.5%PARI WASHINGTON INDIA MASTER FUND, LTD. 5.2%ISIF EQUITY EX-TOP 100 LONG-SHORT FUND 3.3%register as filed 2026-06-30

Filing timeline — what the company told the exchange

CARE Ratings Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015… 28 Sep 2026 · document
Analysts/Institutional Investor Meet/Con. Call Updates. CARE Ratings Limited has informed the Exchange about Schedule of Investor Meet… 24 Sep 2026 · document
Analysts/Institutional Investor Meet/Con. Call Updates. CARE Ratings Limited has informed the Exchange about Schedule of Investor Meet… 21 Sep 2026 · document
Analysts/Institutional Investor Meet/Con. Call Updates. CARE Ratings Limited has informed the Exchange about Schedule of Investor Meet… 15 Sep 2026 · document
CARE Ratings Limited has informed the Exchange about Copy of Newspaper Publication… 11 Sep 2026 · document
Analysts/Institutional Investor Meet/Con. Call Updates. CARE Ratings Limited has informed the Exchange about Schedule of InvestorMeet… 04 Sep 2026 · document
Analysts/Institutional Investor Meet/Con. Call Updates. CARE Ratings Limited has informed the Exchange about Cancellation of Investor Meet… 03 Sep 2026 · document
ESOP/ESOS/ESPS. CARE Ratings Limited has informed the Exchange regarding Allotment of 24,500 equity shares pursuant to exercise of ESOP… 02 Sep 2026 · document

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →

India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances